Fehm T - Search Results

1

Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.

Fehm T, Jäger W, Krämer S, Sohn C, Solomayer E, Wallwiener D, Gebauer G. Fehm T, et al. Anticancer Res. 2004 May-Jun;24(3b):1987-92. Anticancer Res. 2004. PMID: 15274389 Free article.

2

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients.

Fehm T, Maimonis P, Weitz S, Teramoto Y, Katalinic A, Jäger W. Fehm T, et al. Breast Cancer Res Treat. 1997 Mar;43(1):87-95. doi: 10.1023/a:1005700812422. Breast Cancer Res Treat. 1997. PMID: 9065602

3

The prognostic significance of c-erbB-2 serum protein in metastatic breast cancer.

Fehm T, Maimonis P, Katalinic A, Jäger WH. Fehm T, et al. Oncology. 1998 Jan-Feb;55(1):33-8. doi: 10.1159/000011832. Oncology. 1998. PMID: 9428373

4

CA 125 elevations in patients with malignant lymphomas.

Fehm T, Beck E, Valerius T, Gramatzki M, Jäger W. Fehm T, et al. Tumour Biol. 1998;19(4):283-9. doi: 10.1159/000030019. Tumour Biol. 1998. PMID: 9679739

5

Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up.

Gebauer G, Fehm T, Merkle E, Beck EP, Lang N, Jäger W. Gebauer G, et al. Among authors: fehm t. J Clin Oncol. 2001 Aug 15;19(16):3669-74. doi: 10.1200/JCO.2001.19.16.3669. J Clin Oncol. 2001. PMID: 11504748

6

Tumor size, axillary lymph node status and steroid receptor expression in breast cancer: prognostic relevance 5 years after surgery.

Gebauer G, Fehm T, Lang N, Jäger W. Gebauer G, et al. Among authors: fehm t. Breast Cancer Res Treat. 2002 Sep;75(2):167-73. doi: 10.1023/a:1019601928290. Breast Cancer Res Treat. 2002. PMID: 12243509

7

Clinical utility of serial serum c-erbB-2 determinations in the follow-up of breast cancer patients.

Fehm T, Gebauer G, Jäger W. Fehm T, et al. Breast Cancer Res Treat. 2002 Sep;75(2):97-106. doi: 10.1023/a:1019601022456. Breast Cancer Res Treat. 2002. PMID: 12243512

8

Cytotoxic effect of conjugates of doxorubicin and human chorionic gonadotropin (hCG) in breast cancer cells.

Gebauer G, Fehm T, Beck EP, Berkholz A, Licht P, Jäger W. Gebauer G, et al. Among authors: fehm t. Breast Cancer Res Treat. 2003 Jan;77(2):125-31. doi: 10.1023/a:1021301001208. Breast Cancer Res Treat. 2003. PMID: 12602911

9

Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.

Gebauer G, Fehm T, Merkle E, Jaeger W, Mitze M. Gebauer G, et al. Among authors: fehm t. Anticancer Res. 2003 Sep-Oct;23(5b):4319-24. Anticancer Res. 2003. PMID: 14666645

10

Time is an important factor when processing samples for the detection of disseminated tumor cells in blood/bone marrow by reverse transcription-PCR.

Becker S, Becker-Pergola G, Fehm T, Wallwiener D, Solomayer EF. Becker S, et al. Among authors: fehm t. Clin Chem. 2004 Apr;50(4):785-6. doi: 10.1373/clinchem.2003.025510. Clin Chem. 2004. PMID: 15044349 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters